Selected research
Industry Research
Automated DNA Sequencers Industry Research Report 2026
Market perspective
The global Automated DNA Sequencers market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Automated DNA Sequencers is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Automated DNA Sequencers is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Automated DNA Sequencers is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Automated DNA Sequencers include Roche, Thermo Fisher Scientific, Illumina, Danaher, Agilent Technologies, Beckman Coulter, Abbott Molecular, Promega and QIAGEN, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Automated DNA Sequencers market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Automated DNA Sequencers Market by Company
Roche
Thermo Fisher Scientific
Illumina
Danaher
Agilent Technologies
Beckman Coulter
Abbott Molecular
Promega
QIAGEN
Oxford Nanopore Technologies
BGI Group
Berry Genomics
Shanghai Xinzhen
CapitalBio Technology
Automated DNA Sequencers Segment by Type
Chain Terminator DNA Sequencing
Next Generation DNA Sequencing
Automated DNA Sequencers Segment by Application
Pharmaceutical and Biotechnology
Hospitals and Clinics
Scientific Research
Automated DNA Sequencers Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Automated DNA Sequencers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Automated DNA Sequencers and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Automated DNA Sequencers.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Automated DNA Sequencers manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Automated DNA Sequencers by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Automated DNA Sequencers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Chain Terminator DNA Sequencing
- Next Generation DNA Sequencing
Applications
- Pharmaceutical and Biotechnology
- Hospitals and Clinics
- Scientific Research
Companies covered
- Roche
- Thermo Fisher Scientific
- Illumina
- Danaher
- Agilent Technologies
- Beckman Coulter
- Abbott Molecular
- Promega
- QIAGEN
- Oxford Nanopore Technologies
- BGI Group
- Berry Genomics
- Shanghai Xinzhen
- CapitalBio Technology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Automated DNA Sequencers Market Size (2021-2032)
- 2.2.2 Global Automated DNA Sequencers Sales (2021-2032)
- 2.2.3 Global Automated DNA Sequencers Market Average Price (2021-2032)
- 2.3 Automated DNA Sequencers by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Chain Terminator DNA Sequencing
- 2.3.3 Next Generation DNA Sequencing
- 2.4 Automated DNA Sequencers by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmaceutical and Biotechnology
- 2.4.3 Hospitals and Clinics
- 2.4.4 Scientific Research
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Automated DNA Sequencers Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Automated DNA Sequencers Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Automated DNA Sequencers Revenue of Manufacturers (2021-2026)
- 3.4 Global Automated DNA Sequencers Average Price by Manufacturers (2021-2026)
- 3.5 Global Automated DNA Sequencers Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Automated DNA Sequencers, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Automated DNA Sequencers, Product Type & Application
- 3.8 Global Manufacturers of Automated DNA Sequencers, Established Date
- 3.9 Global Automated DNA Sequencers Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Roche
- 4.1.1 Roche Company Information
- 4.1.2 Roche Business Overview
- 4.1.3 Roche Automated DNA Sequencers Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Roche Automated DNA Sequencers Product Portfolio
- 4.1.5 Roche Recent Developments
- 4.2 Thermo Fisher Scientific
- 4.2.1 Thermo Fisher Scientific Company Information
- 4.2.2 Thermo Fisher Scientific Business Overview
- 4.2.3 Thermo Fisher Scientific Automated DNA Sequencers Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Thermo Fisher Scientific Automated DNA Sequencers Product Portfolio
- 4.2.5 Thermo Fisher Scientific Recent Developments
- 4.3 Illumina
- 4.3.1 Illumina Company Information
- 4.3.2 Illumina Business Overview
- 4.3.3 Illumina Automated DNA Sequencers Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Illumina Automated DNA Sequencers Product Portfolio
- 4.3.5 Illumina Recent Developments
- 4.4 Danaher
- 4.4.1 Danaher Company Information
- 4.4.2 Danaher Business Overview
- 4.4.3 Danaher Automated DNA Sequencers Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Danaher Automated DNA Sequencers Product Portfolio
- 4.4.5 Danaher Recent Developments
- 4.5 Agilent Technologies
- 4.5.1 Agilent Technologies Company Information
- 4.5.2 Agilent Technologies Business Overview
- 4.5.3 Agilent Technologies Automated DNA Sequencers Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Agilent Technologies Automated DNA Sequencers Product Portfolio
- 4.5.5 Agilent Technologies Recent Developments
- 4.6 Beckman Coulter
- 4.6.1 Beckman Coulter Company Information
- 4.6.2 Beckman Coulter Business Overview
- 4.6.3 Beckman Coulter Automated DNA Sequencers Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Beckman Coulter Automated DNA Sequencers Product Portfolio
- 4.6.5 Beckman Coulter Recent Developments
- 4.7 Abbott Molecular
- 4.7.1 Abbott Molecular Company Information
- 4.7.2 Abbott Molecular Business Overview
- 4.7.3 Abbott Molecular Automated DNA Sequencers Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Abbott Molecular Automated DNA Sequencers Product Portfolio
- 4.7.5 Abbott Molecular Recent Developments
- 4.8 Promega
- 4.8.1 Promega Company Information
- 4.8.2 Promega Business Overview
- 4.8.3 Promega Automated DNA Sequencers Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Promega Automated DNA Sequencers Product Portfolio
- 4.8.5 Promega Recent Developments
- 4.9 QIAGEN
- 4.9.1 QIAGEN Company Information
- 4.9.2 QIAGEN Business Overview
- 4.9.3 QIAGEN Automated DNA Sequencers Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 QIAGEN Automated DNA Sequencers Product Portfolio
- 4.9.5 QIAGEN Recent Developments
- 4.10 Oxford Nanopore Technologies
- 4.10.1 Oxford Nanopore Technologies Company Information
- 4.10.2 Oxford Nanopore Technologies Business Overview
- 4.10.3 Oxford Nanopore Technologies Automated DNA Sequencers Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Oxford Nanopore Technologies Automated DNA Sequencers Product Portfolio
- 4.10.5 Oxford Nanopore Technologies Recent Developments
- 4.11 BGI Group
- 4.11.1 BGI Group Company Information
- 4.11.2 BGI Group Business Overview
- 4.11.3 BGI Group Automated DNA Sequencers Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 BGI Group Automated DNA Sequencers Product Portfolio
- 4.11.5 BGI Group Recent Developments
- 4.12 Berry Genomics
- 4.12.1 Berry Genomics Company Information
- 4.12.2 Berry Genomics Business Overview
- 4.12.3 Berry Genomics Automated DNA Sequencers Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Berry Genomics Automated DNA Sequencers Product Portfolio
- 4.12.5 Berry Genomics Recent Developments
- 4.13 Shanghai Xinzhen
- 4.13.1 Shanghai Xinzhen Company Information
- 4.13.2 Shanghai Xinzhen Business Overview
- 4.13.3 Shanghai Xinzhen Automated DNA Sequencers Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Shanghai Xinzhen Automated DNA Sequencers Product Portfolio
- 4.13.5 Shanghai Xinzhen Recent Developments
- 4.14 CapitalBio Technology
- 4.14.1 CapitalBio Technology Company Information
- 4.14.2 CapitalBio Technology Business Overview
- 4.14.3 CapitalBio Technology Automated DNA Sequencers Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 CapitalBio Technology Automated DNA Sequencers Product Portfolio
- 4.14.5 CapitalBio Technology Recent Developments
5 Global Automated DNA Sequencers Market Scenario by Region
- 5.1 Global Automated DNA Sequencers Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Automated DNA Sequencers Sales by Region: 2021-2032
- 5.2.1 Global Automated DNA Sequencers Sales by Region: 2021-2026
- 5.2.2 Global Automated DNA Sequencers Sales by Region: 2027-2032
- 5.3 Global Automated DNA Sequencers Revenue by Region: 2021-2032
- 5.3.1 Global Automated DNA Sequencers Revenue by Region: 2021-2026
- 5.3.2 Global Automated DNA Sequencers Revenue by Region: 2027-2032
- 5.4 North America Automated DNA Sequencers Market Facts & Figures by Country
- 5.4.1 North America Automated DNA Sequencers Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Automated DNA Sequencers Sales by Country (2021-2032)
- 5.4.3 North America Automated DNA Sequencers Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Automated DNA Sequencers Market Facts & Figures by Country
- 5.5.1 Europe Automated DNA Sequencers Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Automated DNA Sequencers Sales by Country (2021-2032)
- 5.5.3 Europe Automated DNA Sequencers Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Automated DNA Sequencers Market Facts & Figures by Country
- 5.6.1 Asia Pacific Automated DNA Sequencers Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Automated DNA Sequencers Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Automated DNA Sequencers Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Automated DNA Sequencers Market Facts & Figures by Country
- 5.7.1 South America Automated DNA Sequencers Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Automated DNA Sequencers Sales by Country (2021-2032)
- 5.7.3 South America Automated DNA Sequencers Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Automated DNA Sequencers Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Automated DNA Sequencers Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Automated DNA Sequencers Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Automated DNA Sequencers Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Automated DNA Sequencers Sales by Type (2021-2032)
- 6.1.1 Global Automated DNA Sequencers Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Automated DNA Sequencers Sales Market Share by Type (2021-2032)
- 6.2 Global Automated DNA Sequencers Revenue by Type (2021-2032)
- 6.2.1 Global Automated DNA Sequencers Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Automated DNA Sequencers Revenue Market Share by Type (2021-2032)
- 6.3 Global Automated DNA Sequencers Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Automated DNA Sequencers Sales by Application (2021-2032)
- 7.1.1 Global Automated DNA Sequencers Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Automated DNA Sequencers Sales Market Share by Application (2021-2032)
- 7.2 Global Automated DNA Sequencers Revenue by Application (2021-2032)
- 7.2.1 Global Automated DNA Sequencers Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Automated DNA Sequencers Revenue Market Share by Application (2021-2032)
- 7.3 Global Automated DNA Sequencers Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Automated DNA Sequencers Value Chain Analysis
- 8.1.1 Automated DNA Sequencers Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Automated DNA Sequencers Production Mode & Process
- 8.2 Automated DNA Sequencers Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Automated DNA Sequencers Distributors
- 8.2.3 Automated DNA Sequencers Customers
9 Global Automated DNA Sequencers Analyzing Market Dynamics
- 9.1 Automated DNA Sequencers Industry Trends
- 9.2 Automated DNA Sequencers Industry Drivers
- 9.3 Automated DNA Sequencers Industry Opportunities and Challenges
- 9.4 Automated DNA Sequencers Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst